tsn

Celltex IND Approved by FDA to Launch Clinical Trial to Investigate Prophylactic Safety & Efficacy of AdMSCs against COVID-19

 29223
0 comment
Staff at TrialSite | Quality Journalism
Jun. 27, 2020, 1:32 p.m.

TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2024 - Trial Site News